Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...

Though relapsing-remitting multiple sclerosis, or RRMS, can be managed with many of the approved treatments for MS symptoms, there is still no scientifically proven, FDA-cleared way to predict when or ...

The medical toolbox for treating multiple sclerosis (MS) has progressed in leaps and bounds over the last two decades, as highlighted by the recent approval of Ocrevus for the most severe and ...

"The whole future of precision medicine for MS and Parkinson's is managing to the biology of the disease to individualize the ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

Researchers have created a blood test to detect multiple sclerosis (MS) patients' immunological responses, which may help us understand and treat the disease. Around 2.8 million individuals worldwide ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

Peter L. Salgo, MD: You alluded to some things that I want to pin down, radiologic studies: CT [computed tomography], MRI [magnetic resonance imaging]. And something that nobody’s mentioned yet, the ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Multiple sclerosis (MS) is a central nervous system (CNS) disease that causes damage to the brain and spinal cord. Radiology scans such as MRIs or CTs can help diagnose the condition, along with other ...

Researchers in the Rady Faculty of Health Sciences are exploring whether a person's genetic risk for depression can help ...